Umoja BiopharmaとTreeFrog Therapeuticsは がん免疫分野におけるex vivo他家由来療法が現在直面する課題 に対処するため協力関係の締結を発表

TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and...